Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001839882-23-014903
Filing Date
2023-06-05
Accepted
2023-06-05 17:26:50
Documents
2
Group Members
EBRAHIM VERSI

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP versi-sc13d_052523.htm SC 13D 89601
2 JOINT FILING AGREEMENT ex-1.htm EX-1 8171
  Complete submission text file 0001839882-23-014903.txt   99360
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Subject) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45279 | Film No.: 23993950
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 GREENE AVE BROOKLYN NY 11238
Business Address 75 GREENE AVE BROOKLYN NY 11238 9082562186
Versi Group LLC (Filed by) CIK: 0001979074 (see all company filings)

EIN.: 462828260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D